Speakeasy Cannabis Club Ltd.

OTC: SPBBF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Rock Creek, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 22

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ market scale, Piotroski F

Methodology →

Revenue TTM

$759.9k

Rev growth YoY (TTM)

+16129.5%

Net income (FY)

-$2.0M

Employees

—

Market cap

$1.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02020

Net income-$2.0M-$2.0M2020

Operating income-$4.1M-$4.1M2020

Total assets$17.8M$17.8M2020

Liabilities$4.7M$4.7M2020

Equity$13.0M$13.0M2020

Revenue trend

FY2016 – FY2020 · USD

FY16

FY17

FY18

FY19

FY20

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Speakeasy Cannabis Club Ltd. booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Evolutionary Genomics, Inc.——PsyBio Therapeutics Corp——Biomagnetics Diagnostics Corp.——Applied Biosciences Corp.——

Key facts

CEOPatrick Geen

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersRock Creek, BC

ExchangeOTC: SPBBF

Employees—

IPO date2018-05-01

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.